Concepedia

Hiroki Ishikawa

HI

Statistics

Publications

67

Citations

4.4K

H-Index

31

Active since

1985

Affiliations

Nagasaki University(Current)

Bristol-Myers Squibb (Japan)

Toranomon Hospital

Kyoto Prefectural University of Medicine

Sapporo Kosei General Hospital

Hiroki Ishikawa is an author at Nagasaki University specializing in viral hepatitis, antiviral therapy, and medicine.

ORCID

Publications per year

1985–2023

67

Publications

67

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda et al. · Hepatology · 2014 · 539 citations · Full text

, , +17

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

Kazuaki Chayama, Shoichi Takahashi, Joji Toyota et al. · Hepatology · 2011 · 335 citations

, , +17

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

Kazuyuki Ohata, Keisuke Hamasaki, Kan Toriyama et al. · Cancer · 2003 · 319 citations · Full text

, , +17

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki et al. · Journal of Hepatology · 2012 · 236 citations

, , +14

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

Yoshio Sumida, Toshiaki Nakashima, Takaharu Yoh et al. · Journal of Hepatology · 2002 · 214 citations · Full text

, , +13

1–5 of 67